Navigation Links
BioMed Realty Trust Announces Tax Treatment of 2010 Distributions
Date:1/19/2011

SAN DIEGO, Jan. 19, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2010 distributions as follows:Security Description: Common StockCUSIP: 09063H107Ticker Symbol: BMRRecord DatePayable DateTotal Distribution Per ShareAllocable to 2010Taxable Ordinary DividendReturn of CapitalLong-Term Capital GainUnrecaptured Section 1250 Gain12/31/2009

1/15/2010

$0.140000

$0.140000

$0.090527

$0.049473

$0.000000

$0.0000003/31/2010

4/15/2010

$0.140000

$0.140000

$0.090527

$0.049473

$0.000000

$0.0000006/30/2010

7/15/2010

$0.150000

$0.150000

$0.096994

$0.053006

$0.000000

$0.0000009/30/2010

10/15/2010

$0.170000

$0.170000

$0.109926

$0.060074

$0.000000

$0.000000Totals

$0.600000

$0.600000

$0.387974

$0.212026

$0.000000

$0.000000Security Description: 7.375% Series A Cumulative Redeemable Preferred StockCUSIP: 09063H206Ticker Symbol: BMR PR ARecord DatePayable DateTotal Distribution Per ShareAllocable to 2010Taxable Ordinary DividendReturn of CapitalLong-Term Capital GainUnrecaptured Section 1250 Gain12/31/2009

1/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.0000003/31/2010

4/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.0000006/30/2010

7/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.0000009/30/2010

10/15/2010

$0.460940

$0.460940

$0.460940

$0.000000

$0.000000

$0.000000Totals

$1.843760

$1.843760

$1.843760

$0.000000

$0.000000

$0.000000The distributions payable on January 17, 2011 to shareholders of record on December 31, 2010, as previously announced on December 15, 2010, are considered 2011 distributions for federal income tax purposes.

The company did not incur any foreign taxes during 2010.  Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty TrustBioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 85 properties, representing 147 buildings with approximately 12.2 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research.  Additional information is available at www.biomedrealty.com.


'/>"/>

SOURCE BioMed Realty Trust, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations
2. BioMedixs TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification
3. BioMedical Enterprises, Inc. (BME) Introduces the HammerLock™ Shape Memory Device for Hammertoes.
4. Synapse Biomedical Receives FDA Humanitarian Use Device Designation for Amyotrophic Lateral Sclerosis (ALS)
5. DSM Biomedical to be Key Contributor at the Surfaces in Biomaterials Foundations 2010 BioInterface Symposium and Workshop
6. BioMed Realty Trust Announces Exercise of Over-Allotment Option for Common Stock
7. DuPont and DSM Announce Joint Venture in Surgical Biomedical Materials
8. ETC Biomedical Systems Offers New FDA Approved Hyperbaric Oxygen Therapy (HBOT) Medical Device
9. BINDER BIOMEDICAL, INC. Announces Official Launch of the NEWTON™ Intervertebral Body Fusion Spinal Spacer System
10. Crux Biomedical Named One of Top 50 Companies to Watch
11. Crux Biomedical Enrolls First Patient in Its Retrieve 2 U.S. Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
Breaking Medicine News(10 mins):